The observation that re-activation of telomerase not only reverses anemia, but also restores homeostasis in other hematopoietic cell lineages, indicates a potential therapeutic approach, for example through TERT mRNA delivery [60], for bone marrow disorders that are associated with short telomeres. This evidence concerns the gene TERT and anemia (phenotype).